DermNet provides Google Translate, a free machine translation service. Note that this may not provide an exact translation in all languages


Generalised pustular psoriasis

Author: Vanessa Ngan, Staff Writer, 2003. Updated by Hon A/Prof Amanda Oakley, Dermatologist, Hamilton, New Zealand, September 2014.

Generalised pustular psoriasis — codes and concepts

What is generalised pustular psoriasis?

Generalised pustular psoriasis is a rare and serious skin disorder that presents with flares of widespread sterile pustules on a background of red and tender skin. It is also known as acute generalised pustular psoriasis of von Zumbusch.

Related pustular disorders include:

Generalised pustular psoriasis

See more images of generalised pustular psoriasis.

What causes generalised pustular psoriasis?

Generalised pustular psoriasis is an inflammatory skin disease. Recent research suggests generalised pustular psoriasis is distinct from psoriasis, with a different pattern of immune activation. Generalised pustular psoriasis has been associated with abnormalities in the cytokine (messenger protein) interleukin -36-receptor-antagonist signalling. This is due to recessive IL36RN gene mutations. These mutations are also found in some patients with AGEP, palmoplantar pustulosis and acrodermatitis continua of Hallopeau.

About 10% of patients with generalised pustular psoriasis have a preceding history of psoriasis, in which there are persistent, circumscribed, red and scaly plaques. In these patients, CARD14 gene gain-of-function abnormalities have been reported.

Possible trigger factors for flares of generalised pustular psoriasis may include:

Strong, irritating topical preparations such as coal tar, dithranol and withdrawal of strong topical corticosteroids can lead to localised areas of pustulosis, often associated with existing plaques of psoriasis.

What are the signs and symptoms of generalised pustular psoriasis?

Generalised pustular psoriasis is characterised by recurrent acute flares.

  • Initially, the skin becomes dry, fiery red and tender.
  • Within hours, 2–3 mm pustules appear.
  • After a day, the small pustules coalesce to form lakes of pus
  • These dry out and peel to leave a glazed, smooth surface on which new crops of pustules may appear.
  • Successive crops of pustules may appear and erupt every few days or weeks.

Systemic symptoms

Flares of generalised pustular psoriasis may result in:

  • Fever and chills (or hypothermia)
  • A headache
  • Rapid pulse rate
  • Loss of appetite and nausea
  • Thirst and dehydration
  • Muscle weakness
  • Leg swelling.

Remission occurs within days or weeks and the skin reverts to its previous state or erythroderma may develop. Relapses are common.

How is generalised pustular psoriasis diagnosed?

Generalised pustular psoriasis is often suspected clinically by experienced dermatologists. However, the following tests are usually undertaken to confirm the diagnosis and to identify potential complications.

What are the complications of generalised pustular psoriasis?

Death can result from cardiorespiratory failure during the acute eruptive phase of generalised pustular psoriasis, so it is essential to treat it as early as possible. Older patients are at highest risk. Other complications include:

  • Secondary bacterial infection
  • The blood count may show anaemia, neutrophilia, lymphopenia
  • Raised inflammatory markers such as C-reactive protein (CRP)
  • Disturbed protein and electrolyte balance, low albumin, low calcium and low zinc
  • High-output cardiac failure
  • Renal and liver impairment
  • Protein-losing enteropathy
  • Peripheral neuropathy
  • Malabsorption of nutrients and therapeutic drugs.

What treatment is available for generalised pustular psoriasis?

Generalised pustular psoriasis can be life-threatening, so hospitalisation is usually required. The aim is to prevent further fluid loss, stabilise body temperature and restore electrolyte imbalance. Specialist care is essential.

Affected areas are treated with bland topical compresses using emollients and low potency topical steroid creams.

Systemic medications may include:

Anti-IL36 monoclonal antibodies are being evaluated for their effectiveness in generalised pustular psoriasis.




On DermNet NZ

Other websites

Books about skin diseases


Related information

Sign up to the newsletter